Yuko Hashimoto

3.1k total citations
82 papers, 2.3k citations indexed

About

Yuko Hashimoto is a scholar working on Molecular Biology, Finance and Oncology. According to data from OpenAlex, Yuko Hashimoto has authored 82 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Finance and 17 papers in Oncology. Recurrent topics in Yuko Hashimoto's work include Global Financial Crisis and Policies (13 papers), Protein Kinase Regulation and GTPase Signaling (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). Yuko Hashimoto is often cited by papers focused on Global Financial Crisis and Policies (13 papers), Protein Kinase Regulation and GTPase Signaling (11 papers) and Lymphoma Diagnosis and Treatment (10 papers). Yuko Hashimoto collaborates with scholars based in Japan, United States and Germany. Yuko Hashimoto's co-authors include Michiyuki Matsuda, Takeshi Kurata, Etsuko Kiyokawa, Haruhiko Sugimura, Shinya Tanaka, Takatoshi Ito, Satoshi Hattori, Shin Kobayashi, Takayasu Kurata and T Takenawa and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Yuko Hashimoto

75 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Hashimoto Japan 22 1.3k 587 499 374 295 82 2.3k
George A. Martin United States 25 2.8k 2.2× 845 1.4× 418 0.8× 800 2.1× 920 3.1× 52 4.8k
Devraj Basu United States 23 1.0k 0.8× 162 0.3× 57 0.1× 914 2.4× 434 1.5× 77 2.4k
Yasuhiro Sakai Japan 27 1.0k 0.8× 219 0.4× 78 0.2× 321 0.9× 237 0.8× 163 2.7k
Steven Seelig United States 27 1.4k 1.1× 205 0.3× 57 0.1× 848 2.3× 101 0.3× 69 3.4k
Min Hu Canada 16 1.2k 0.9× 227 0.4× 163 0.3× 1.4k 3.8× 374 1.3× 38 2.6k
Ming Lin China 20 778 0.6× 125 0.2× 69 0.1× 235 0.6× 90 0.3× 51 1.3k
Gregory S. Taylor United States 16 1.3k 1.0× 757 1.3× 34 0.1× 93 0.2× 157 0.5× 28 1.7k
Michael Cuddy United States 20 816 0.6× 183 0.3× 15 0.0× 306 0.8× 176 0.6× 44 1.3k
Peter Diamond Australia 20 616 0.5× 35 0.1× 61 0.1× 409 1.1× 198 0.7× 38 1.3k
Arti Gaur United States 14 2.8k 2.2× 146 0.2× 39 0.1× 717 1.9× 243 0.8× 28 3.8k

Countries citing papers authored by Yuko Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Yuko Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Hashimoto more than expected).

Fields of papers citing papers by Yuko Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Hashimoto. The network helps show where Yuko Hashimoto may publish in the future.

Co-authorship network of co-authors of Yuko Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Hashimoto. A scholar is included among the top collaborators of Yuko Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Hashimoto. Yuko Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kato, Daiki, et al.. (2024). Anti-tumor effect of proteasome inhibitor on canine urothelial carcinoma. Journal of Veterinary Medical Science. 86(9). 961–965.
2.
Muto, Y., Saori Miura, Yuko Hashimoto, et al.. (2023). Brain-specific glycosylation enzyme GnT-IX maintains levels of protein tyrosine phosphatase receptor PTPRZ, thereby mediating glioma growth. Journal of Biological Chemistry. 299(9). 105128–105128. 4 indexed citations
3.
Kato, Daiki, Yuko Hashimoto, James Chambers, et al.. (2023). Podoplanin Drives Amoeboid Invasion in Canine and Human Mucosal Melanoma. Molecular Cancer Research. 21(11). 1205–1219.
5.
6.
Hashimoto, Yuko, et al.. (2021). Inactivation of Bacteria and Fungus by Ultrasonic Cavitation. JAPANESE JOURNAL OF MULTIPHASE FLOW. 35(1). 11–18. 2 indexed citations
7.
Hashimoto, Yuko, et al.. (2020). Demographics and the Housing Market: Japan's Disappearing Cities. IMF Working Paper. 2020(192). 2 indexed citations
8.
Kato, Daiki, Masaya Tsuboi, Ryohei Yoshitake, et al.. (2020). Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer. Journal of Veterinary Medical Science. 82(6). 804–808. 15 indexed citations
10.
Hashimoto, Yuko, et al.. (2010). Effects of aging on thoracic and lumbar spinal mobility. Taiikugaku kenkyu (Japan Journal of Physical Education Health and Sport Sciences). 55(2). 333–342. 1 indexed citations
11.
Hirayama, Kouichi, Masaki Kobayashi, Yuko Hashimoto, et al.. (2004). Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis. American Journal of Kidney Diseases. 44(1). 57–63. 26 indexed citations
13.
Ohba, Yusuke, Naoki Mochizuki, Shigeko Yamashita, et al.. (2000). Rap2 as a Slowly Responding Molecular Switch in the Rap1 Signaling Cascade. Molecular and Cellular Biology. 20(16). 6074–6083. 97 indexed citations
14.
Matsumoto, Tarô, Koutaro Yokote, Minoru Takemoto, et al.. (2000). Differential Interaction of CrkII Adaptor Protein with Platelet-Derived Growth Factor α- and β-Receptors Is Determined by Its Internal Tyrosine Phosphorylation. Biochemical and Biophysical Research Communications. 270(1). 28–33. 15 indexed citations
15.
Ichiba, Tamotsu, Yuko Hashimoto, Mie Nakaya, et al.. (1999). Activation of C3G Guanine Nucleotide Exchange Factor for Rap1 by Phosphorylation of Tyrosine 504. Journal of Biological Chemistry. 274(20). 14376–14381. 92 indexed citations
16.
Hashimoto, Yuko, Etsuko Kiyokawa, Mie Nakaya, et al.. (1999). Epidermal Growth Factor‐dependent Dissociation of CrkII Proto‐oncogene Product from the Epidermal Growth Factor Receptor in Human Glioma Cells. Japanese Journal of Cancer Research. 90(10). 1096–1103. 4 indexed citations
17.
Nishihara, Hiroshi, Shin Kobayashi, Yuko Hashimoto, et al.. (1999). Non-adherent cell-specific expression of DOCK2, a member of the human CDM-family proteins. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1452(2). 179–187. 71 indexed citations
18.
Nakamura, Naoya, et al.. (1998). Most of CD30+ anaplastic large cell lymphoma of B cell type show a somatic mutation in the IgH V region genes. Leukemia. 12(5). 753–757. 22 indexed citations
19.
Hashimoto, Yuko, Etsuko Kiyokawa, Satoshi Ota, et al.. (1998). Phosphorylation of CrkII Adaptor Protein at Tyrosine 221 by Epidermal Growth Factor Receptor. Journal of Biological Chemistry. 273(27). 17186–17191. 53 indexed citations
20.
Nakamura, Naoya, et al.. (1996). The relationship between the gene mutation of p53 and the protein expression of p53 and Ki‐67 in non‐Hodgkin's iymphomas. Pathology International. 46(2). 130–136. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026